Related Experiment Video
Updated: Sep 25, 2025
08:01
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
2.0K
Dissecting and Reconstructing Matrix in Malignant Mesothelioma Through Histocell-Histochemistry Gradients for
Marcelo Luiz Balancin1, Camila Machado Baldavira1, Tabatha Gutierrez Prieto1
1Laboratory of Genomics and Histomorphometry, Department of Pathology, University of São Paulo Medical School (USP), São Paulo, Brazil.
Frontiers in Medicine
|May 2, 2022
Summary
Understanding malignant pleural mesothelioma (MM) heterogeneity is key. This study reveals distinct extracellular matrix (ECM) compositions in MM subtypes, suggesting new therapeutic targets for improved patient outcomes.
Area of Science:
- Oncology
- Pathology
- Biochemistry
Background:
- Malignant pleural mesotheliomas (MM) exhibit heterogeneous histology and clinical behavior, with epithelioid, sarcomatoid, and biphasic cell types.
- Histochemical gradients offer insights into tumor heterogeneity and classification.
- Characterizing MM cell populations aids in understanding invasion and disease progression mechanisms.
Purpose of the Study:
- To characterize tumor cell populations and the extracellular matrix (ECM) matrisome in malignant pleural mesotheliomas (MM).
- To develop a 3D reconstruction protocol for quantifying the ECM.
- To examine the clinical association between matricellular factors and patient outcomes.
Main Methods:
- Hematoxylin and eosin staining for tumor cell characterization.
- Movat's pentachrome staining to analyze the ECM matrisome.
- Computerized semi-assisted protocol for 3D ECM quantification and reconstruction.
Main Results:
- Epithelioid MM showed higher elastin and fibrin content.
- Sarcomatoid MM displayed greater prevalence of hyaluronic acid and total collagen.
- 3D reconstruction revealed collagen I and III forming channels around neoplastic cell blocks, constituting 14% of the total volume.
Conclusions:
- Differential matricellular phenotypes in MM can inform translational studies for improved patient outcomes.
- The matrisome may be utilized by cancer cells for disease expansion.
- Targeting collagen, elastin, or hyaluronic acid presents potential therapeutic strategies for MM.
